University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

The real-world impact of Glucagon-like peptide 1 receptor agonists on asthma control in people with high risk asthma and obesity

Simple item page
dc.contributor.authorKaplan, Alan
dc.contributor.authorHeatley, Heath
dc.contributor.authorTownend, John
dc.contributor.authorSkinner, Derek
dc.contributor.authorCarter, Victoria
dc.contributor.authorHubbard, Richard
dc.contributor.authorTan, Tze Lee
dc.contributor.authorKoh, Mariko Siyue
dc.contributor.authorPrice, David
dc.date.accessioned2025-06-18T15:14:01Z
dc.date.available2025-06-18T15:14:01Z
dc.date.issued2025-06
dc.description.statusPeer revieweden
dc.format.extent7
dc.format.extent253316
dc.identifier302108911
dc.identifier5120d628-fcb0-4add-8343-8d108d99a9dd
dc.identifier105002171129
dc.identifier.citationKaplan, A, Heatley, H, Townend, J, Skinner, D, Carter, V, Hubbard, R, Tan, T L, Koh, M S & Price, D 2025, 'The real-world impact of Glucagon-like peptide 1 receptor agonists on asthma control in people with high risk asthma and obesity', Advances in Therapy, vol. 42, pp. 2950–2956. https://doi.org/10.1007/s12325-025-03175-xen
dc.identifier.doi10.1007/s12325-025-03175-x
dc.identifier.issn0741-238X
dc.identifier.urihttps://hdl.handle.net/2164/25583
dc.identifier.vol42en
dc.language.isoeng
dc.relation.ispartofAdvances in Therapyen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectAsthmaen
dc.subjectObesityen
dc.subjectAsthma outcomesen
dc.subjectGLP1sen
dc.subjectR Medicine (General)en
dc.subjectSupplementary Dataen
dc.subjectDASen
dc.subjectLinken
dc.subject.lccR1en
dc.titleThe real-world impact of Glucagon-like peptide 1 receptor agonists on asthma control in people with high risk asthma and obesityen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Kaplan_etal_AT_The_Real_World_VoR.pdf
Size:
247.38 KB
Format:
Adobe Portable Document Format
Download

Collections

All research